Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award
18.11.2025 16:00:00 CET | news aktuell GmbH | Press Release
- Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy
- One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time
- Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”
Wiesbaden, November 18, 2025 – At a festive ceremony in the Hessian State Chancellery, Dr. Carl June (University of Pennsylvania) and Dr. Michel Sadelain (Columbia University) were presented with the inaugural Broermann Medical Innovation Award by Minister President Boris Rhein.
With a €1 million endowment, the Broermann Award ranks among the world’s most prestigious medical honors. Founded by Dr. Bernard große Broermann, the visionary founder of the Asklepios Group, the award recognizes the pioneering achievements of the two scientists in developing CAR-T cell therapy for the treatment of cancer.
In the presence of numerous representatives from science, politics, and society, Minister President Rhein honored the work of the award winners and their contribution to the treatment of cancer patients worldwide:
“With their work, Dr. Carl June and Dr. Michel Sadelain demonstrate the immense power that knowledge and passion can unleash. They have the potential to positively impact countless lives.” The head of government presented the Broermann Prize, worth a total of one million euros — one of the world’s most highly endowed awards of its kind praising their “groundbreaking work,” saying: “Dr. Carl June and Dr. Michel Sadelain show that knowledge can change lives and give people new hope for healing.” He further emphasized “The two prizewinners are inspiring role models through their attitude and dedication. With their insight that the immune system itself can become a weapon against cancer, they have opened a new chapter in cancer therapy.”
Prof. Dr. Werner Seeger, Chair of the Broermann Award Jury, emphasized:
“Today’s award ceremony marks a milestone for medical science. Dr. Carl June and Dr. Michel Sadelain have fundamentally transformed cancer treatment through their work on CAR-T cell therapy. Their dedication and pioneering spirit embody the very essence of medical innovation that this award celebrates.”
Dr. Michel Sadelain, Director of the Columbia Initiative in Cell Engineering and Therapy (CICET), accepted the award on behalf of himself and his colleague Dr. Carl June, Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania.
“It is a great honor to receive this recognition together with my colleague Carl June,” said Dr. Sadelain. “We are delighted that our decades of work on CAR-T cell therapy are being recognized internationally. This award is both validation and inspiration to continue advancing our research and developing new treatment options for patients with life-threatening diseases. It is a tremendous motivation for our teams and a resolute dedication to bringing better therapies for patients worldwide.”
Titia Olivia große Broermann, shareholder of the Asklepios Kliniken Group, added:
“For me, this award is more than recognition of scientific excellence – it is a living legacy of my husband’s vision. Bernard große Broermann believed that health should not be left to fate but can be shaped through innovation and care. Today, scientists like Michel Sadelain and Carl June have made this conviction a reality. Their groundbreaking research has transformed medicine and given countless cancer patients new hope – and, in many cases, a new life. For that, we owe them deep gratitude and great respect.”
About the Research
Dr. Carl June and Dr. Michel Sadelain were honored for their pioneering role in the genetic engineering of T cells to specifically target and destroy cancer cells. Using chimeric antigen receptors (CARs), these modified immune cells can identify cancer cells and eliminate them. CAR-T cell therapies have achieved remarkable success in treating leukemia, lymphoma, and multiple myeloma, opening an entirely new chapter in cancer therapy.
About the Laureates
Dr. Carl June (born 1950, Denver, USA) received his M.D. from the Baylor College of Medicine, his Ph.D. from the Fred Hutchinson Cancer Research Center, and founded the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania in 1999. He currently holds the Richard W. Vague Professorship in Immunotherapy.
Dr. Michel Sadelain (born 1960, Paris, France) earned his M.D. from the University of Paris in 1984 and his Ph.D. from the University of Alberta in 1989. After postdoctoral research at the Whitehead Institute for Biomedical Research (MIT), he joined the Memorial Sloan Kettering Cancer Center in New York in 1994. He now leads the Columbia Initiative in Cell Engineering and Therapy (CICET), founded in 2024.
About the Broermann Medical Innovation Award
The Broermann Medical Innovation Award was established in 2024 by Dr. Bernard große Broermann, founder of the Asklepios Kliniken. Guided by his vision to create a healthcare organization that delivers real benefit to patients through innovation, Asklepios became a pioneer in medical technology and digital healthcare solutions. The award continues his legacy, honoring those whose groundbreaking work improves lives and shapes the future of medicine.
Call for Nominations – 2026 Award
The nomination phase for the Broermann Medical Innovation Award 2026 is now open. Nominations of scientists who have made pioneering contributions to medicine, biotechnology, or related disciplines are welcome until March 1, 2026. Further details on eligibility and selection criteria are available on the award’s official website.
Pictures from the award ceremony will be available shortly after the event at the following website: https://www.broermann-award.org/press/
Press Contacts
Broermann Medical Innovation Award
Contact: Corinna Larsen
Tel.: +49 (0) 641 / 985-42302
E-mail: contact@broermann-award.org
Visit Broermann Medical Innovation Award online and on social media:
www.broermann-award.com
www.facebook.com/people/Broermann-Medical-Innovation-Award/61567211302915/
www.linkedin.com/company/broermann-medical-innovation-award/www.mastodon.social/@BroermannMedicalnnovationAward
www.instagram.com/broermannaward
Asklepios Kliniken
Coroporate Communications Marketing Department
Tel.: +49 (0) 40 / 18 18-82 66 36
E-mail: presse@asklepios.com
24—hour press-office on-call service: +49 (0) 40 / 1818-82 8888
Visit Asklepios online and on social media:
www.asklepios.com
www.asklepios.com/gesundheitsmagazin
http://www.youtube.com/asklepioskliniken
de.linkedin.com/company/asklepios
www.instagram.com/asklepioskliniken/
www.facebook.com/asklepioskliniken
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Amid Mounting Global Health Crises, World Health Summit Closes in Berlin with New Commitments14.10.2026 14:13:51 CEST | Press Release
Berlin, October 14, 2026 - The World Health Summit 2026 concluded with new funding commitments, research findings, and initiatives. Under the theme “From Crisis to Resilience: Innovating for Health,” the Summit convened more than 4,000 on-site participants from 130 countries and territories, generated over 50,000 livestream views, and featured more than 400 speakers, including 20 ministers and state secretaries, across 76 sessions.
Innomotics Receives Prestigious EcoVadis Silver Medal – First Assessment Places Company Among Top 15% Globally12.10.2026 11:00:00 CEST | Press Release
Nuremberg – Innomotics, a globally leading provider of electric motors and large drive systems, has earned the coveted EcoVadis Silver Medal in its first-ever assessment. With a strong score of 74 out of 100 points, the company now ranks among the global top 15% of more than 150,000 rated companies. First EcoVadis Rating as Innomotics Participation in the EcoVadis assessment marks an important milestone in Innomotics’ sustainability journey. As a relatively young, independent organization, the first rating provided the opportunity to benchmark its sustainability management against an internationally recognized framework and demonstrate the progress made since becoming a standalone company. Silver Medal: Top 15% Globally The EcoVadis Silver Medal is awarded to the top 15% of companies assessed worldwide. With its achieved score of 74 points, Innomotics not only confirms its position within this leading group but also demonstrates that it meets the rating’s rising requirements – the thre
World Health Summit 2026: Berlin Becomes Global Meeting Point for the Future of Health12.10.2026 08:13:31 CEST | Press Release
Berlin, October 11, 2026 The World Health Summit (WHS) 2026, the leading platform for global health, brings together more than 4,000 participants from 130 countries in Berlin and tens of thousands more online from October 11 to 13. Under the theme "From Crisis to Resilience: Innovating for Health," the Summit convenes leaders from politics, science, civil society, and the private sector. Discussions address Ebola and other infectious diseases, antibiotic resistance, pandemic preparedness, resilient health systems, health care in conflict settings such as Ukraine, and climate-related health threats. The Summit will also address WHO leadership through a conversation with prospective candidates for the next WHO Director-General. Against this backdrop, WHS President Axel R. Pries emphasized the need for innovation and collaboration: "Past achievements and continued progress in global health are increasingly challenged by multiple and overlapping crises. To build resilient, effective, and e
DRF Aviation Services launches on October 1, 20261.10.2026 11:28:06 CEST | Press Release
DRF Luftrettung and DRF Maintenance are joining forces: the newly established DRF Aviation Services combines the two companies’ technical expertise built on more than 50 years of experience in helicopter maintenance, modifications and services. As a “one-stop shop”, DRF Aviation Services provides the full range of services from a single source. Helicopter operators benefit from high levels of reliability and innovative capability.
RM Equity Partners (RMEP) completes generational handover – partners take full ownership1.10.2026 09:30:11 CEST | Press Release
Ruggell (LI), 1 October 2026 – RM Equity Partners (RMEP), the international investment firm focused on asset-light digital businesses, today announces the completion of its generational handover. As of 1 October 2026, the management company is fully owned by the three partners Eugen Benedikt Russ, Chris Wittlinger and Nicola Szekely and the wider team, who will make all new investments independently. With this step, the succession within the founding family is concluded: RMEP operates as a fully independent investment firm with no ownership, management or personnel ties to the Russmedia group. RMEP has grown into one of the most active investors in digital marketplaces, software and consumer platforms in Europe: Assets under management of more than €500 million Annual investment capacity of more than €100 million 50+ portfolio investments, with 95% of revenue generated outside Austria Independent evergreen structure – the partners invest their own capital (principal investing, no exter
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom